Morgan Stanley Nexalin Technology, Inc. Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

Shares

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2024 Aug 14, 2024	BUY	$0.61 - $2.96 $36,481 - $177,022	59,805 New	59,805 $101,000
Q1 2023 May 15, 2023	SELL	$0.75 - $1.22 $588 - $957	-785 Reduced 38.41%	1,259 $1,000
Q4 2022 Feb 14, 2023	BUY	$0.74 - $2.39 $1,512 - $4,885	2,044 New	2,044 $1,000

Others Institutions Holding NXL

# of Institutions

17

Shares Held

484K

Call Options Held

0

Put Options Held

0

Jim Simons Renaissance Technologies LLC | New York, Ny

103K
Shares

$393,078
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

78.7K
Shares

$300,622
0.0% of portfolio
Ken Griffin Citadel Advisors LLC | Chicago, Il

58.2K
Shares

$222,266
0.0% of portfolio
Cvi Holdings, LLC Wilmington, DE

55.5K
Shares

$211,864
0.81% of portfolio
Susquehanna International Group, LLP Bala Cynwyd, PA

42.4K
Shares

$161,903
0.0% of portfolio

About Nexalin Technology, Inc.

Ticker NXL
Exchange
Sector Healthcare
Industry Medical Devices
Shares Outstandng 7,279,960
Market Cap $27.8M

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.